COR Cencora Inc.
Price (delayed)
$244.38
Market cap
$47.39B
P/E Ratio
34.37
Dividend/share
$2.12
EPS
$7.11
Enterprise value
$52.31B
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in
Highlights
Cencora's revenue has increased by 12% YoY and by 3.1% QoQ
COR's gross profit is up by 8% year-on-year
The company's debt has surged by 86% QoQ and by 71% YoY
The equity has plunged by 75% YoY and by 65% from the previous quarter
Key stats
What are the main financial stats of COR
Market
Valuations
Earnings
Shares outstanding
193.92M
Market cap
$47.39B
Enterprise value
$52.31B
Price to earnings (P/E)
34.37
Price to book (P/B)
208.46
Price to sales (P/S)
0.16
EV/EBIT
26.53
EV/EBITDA
21.59
EV/Sales
0.17
Revenue
$303.19B
Gross profit
$10B
Operating income
$2.06B
Net income
$1.4B
EBIT
$1.97B
EBITDA
$2.42B
Free cash flow
-$638.1M
Per share
Balance sheet
Liquidity
EPS
$7.11
EPS diluted
$7.05
Free cash flow per share
-$3.29
Book value per share
$1.17
Revenue per share
$1,564.8
TBVPS
$290.03
Total assets
$69.05B
Total liabilities
$68.69B
Debt
$8.15B
Equity
$226.58M
Working capital
-$4.52B
Debt to equity
35.96
Current ratio
0.92
Quick ratio
0.51
Net debt/EBITDA
2.03
Margins
Efficiency
Dividend
EBITDA margin
0.8%
Gross margin
3.3%
Net margin
0.5%
Operating margin
0.7%
Return on assets
2.1%
Return on equity
193.9%
Return on invested capital
63.3%
Return on capital employed
13.6%
Return on sales
0.7%
Dividend yield
0.87%
DPS
$2.12
Payout ratio
29.8%
COR stock price
How has the Cencora stock price performed over time
Intraday
1.22%
1 week
0.72%
1 month
-1.65%
1 year
3%
YTD
8.77%
QTD
8.77%
Financial performance
How have Cencora's revenue and profit performed over time
Revenue
$303.19B
Gross profit
$10B
Operating income
$2.06B
Net income
$1.4B
Gross margin
3.3%
Net margin
0.5%
The company's net margin fell by 29% YoY
The company's net income fell by 25% YoY and by 7% QoQ
Cencora's operating margin has decreased by 22% YoY
The operating income has contracted by 19% YoY and by 5% from the previous quarter
Growth
What is Cencora's growth rate over time
Valuation
What is Cencora stock price valuation
P/E
34.37
P/B
208.46
P/S
0.16
EV/EBIT
26.53
EV/EBITDA
21.59
EV/Sales
0.17
COR's P/E is 66% above its 5-year quarterly average of 20.4 and 22% above its last 4 quarters average of 27.9
COR's EPS is down by 23% year-on-year and by 6% since the previous quarter
The price to book (P/B) is 133% higher than the last 4 quarters average of 88.4
The equity has plunged by 75% YoY and by 65% from the previous quarter
The P/S is 50% above the 5-year quarterly average of 0.1 but 25% below the last 4 quarters average of 0.2
Cencora's revenue has increased by 12% YoY and by 3.1% QoQ
Efficiency
How efficient is Cencora business performance
Cencora's ROIC has decreased by 44% from the previous quarter and by 39% YoY
The ROE has declined by 38% year-on-year but it has grown by 15% since the previous quarter
The company's return on assets fell by 30% YoY and by 9% QoQ
COR's return on sales is down by 30% year-on-year
Dividends
What is COR's dividend history
DPS
$2.12
Dividend yield
0.87%
Payout ratio
29.8%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Cencora financials performed over time
Cencora's total liabilities has increased by 8% YoY and by 3.6% from the previous quarter
COR's total assets is up by 7% year-on-year and by 2.9% since the previous quarter
The company's debt has surged by 86% QoQ and by 71% YoY
The equity has plunged by 75% YoY and by 65% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.